Trump's Plan to Slash Obesity Drug Prices
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Category : Search result: pharmaceutical pricing
Trump's Drug Price Plan Backfires, Helps Democrats
Former President Trump's proposal to regulate Medicare drug prices faces unexpected consequences as Democrats leverage it to attack Republican positions on healthcare, creating political turmoil.
Trump Reveals Deal to Lower Obesity Drug Costs
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Canada's climate tax credits failing: watchdog report
Shocking audit reveals federal emission reduction tax credits are missing targets and costing taxpayers billions without meaningful environmental impact.
Trump Obesity Drug Deal Boosts Pharma Stocks
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Ontario fiscal update amid carbon tax concerns
Ontario's Finance Minister Peter Bethlenfalvy to deliver fiscal update amid concerns over federal carbon tax increase and its effects on provincial economy and household budgets.
Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board
Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.
Doug Ford's Anti-Carbon Tax Ad: Political Masterclass
Ontario Premier Doug Ford's anti-carbon tax advertising campaign demonstrates brilliant political strategy as public opinion shifts against the federal carbon pricing policy. Discover why this approach is resonating with voters.
Ford Challenges Carney's Carbon Tax Ad Criticism
Ontario Premier Doug Ford challenges former Bank of Canada governor Mark Carney's criticism of provincial carbon tax advertisements, highlighting the ongoing political battle over carbon pricing in Canada.
Ontario Electricity Rates Rise: Bill Changes Explained
Ontario residents face higher electricity costs starting May 1st. Learn how time-of-use and tiered rates are changing and get expert tips to manage your energy bills effectively.
NB Gas Stations Face Closure After Carbon Levy Removal
Gas retailers across New Brunswick warn of potential station closures and job losses as the federal carbon price adjustment at the pumps ends, creating financial uncertainty for the industry.
Top FDA Drug Official Resigns Amid Federal Probe
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Ardena Appoints Chief Quality and Information Officers
Ardena strengthens its leadership with strategic hires of Chief Quality Officer and Chief Information Officer to drive operational excellence and digital transformation in pharmaceutical services.
Kimberly-Clark Buys Tylenol Maker in $48.7B Deal
In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.
Kimberly-Clark Buys Tylenol Maker Kenvue for $4.87B
In a landmark healthcare deal, Kimberly-Clark acquires Kenvue, the consumer health giant behind Tylenol, Band-Aid and Listerine, reshaping the North American healthcare landscape.
Ontario Minister Defends Anti-Carbon Tax Ad as Intentional
Ontario's trade minister staunchly defends a provocative advertisement targeting federal carbon pricing, insisting the controversial messaging was intentional and strategically sound.
Blood Pressure Medication Recall Over Cancer Risk
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Eli Lilly's Weight Loss Drugs Spark Billion-Dollar Bidding War
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Weight-Loss Pill Race Revolutionizes Healthcare Market
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
Boehringer Ingelheim Licenses Novel Autoimmune Treatment
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
Ex-Pharmacy Manager Guilty, Fined $5K for Multiple Violations
A former Melita pharmacy manager faces consequences after being convicted of multiple professional misconduct charges, including improper prescription practices and record-keeping failures.
Page 1 of 1